Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03860363 · ClinicalTrials.gov registry record
Experiences With Automated Surgical Drainage in Cardiac Surgery
A clinical trial, sponsored by Centese.
- Completed
- Registry status
- 28
- Enrollment target
NCT03860363 is a clinical trial that has completed, run by Centese. The registered enrollment target is 28 participants.
The verdict
NCT03860363 has completed, sponsored by Centese.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the Thoraguard Surgical Drainage System in a real-world clinical environment. It is believed that this system will offer functional and clinical benefits over the current standard of care system for the removal of surgical fluids following cardiac surgery. Observations, experiences, and outcomes in a single hospital setting will be collected for the Thoraguard Surgical Drainage System.
Interventions
- DEVICE Blood drainage post cardiac surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2019-02-22 |
| Est. Completion | 2020-05-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03860363
The ClinicalTrials.gov registry entry for NCT03860363 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centese, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood drainage post cardiac surgery is the first listed.
NCT03860363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03860363 about?
NCT03860363 is a clinical study titled "Experiences With Automated Surgical Drainage in Cardiac Surgery". The purpose of this study is to evaluate the Thoraguard Surgical Drainage System in a real-world clinical environment. It is believed that this system will offer functional and clinical benefits over the current standard of care system for the removal of surgical fluids following cardiac surgery. Ob...
What is the current status of trial NCT03860363?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2019-02-22. Estimated completion is 2020-05-30.
What interventions are being tested in trial NCT03860363?
The interventions under investigation include: Blood drainage post cardiac surgery (DEVICE).
Who is sponsoring clinical trial NCT03860363?
This trial is sponsored by Centese, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.